Celanese Showcases Sustainable Medical EVA Copolymers at ICMD Event in Shanghai

Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will showcase its sustainable and proven Ateva® G Medical grades of ethylene vinyl acetate (EVA) copolymers at the 2015 International Component and Manufacturing Design (ICMD) tradeshow May 15-18 in Shanghai, China. The use of EVA in medical applications will be demonstrated at booth J39-J41 in Hall 6.1 of the Pacifico Convention Plaza in Shanghai.

“Celanese Ateva® G Medical EVA copolymers work well alone or in polymer blends and are a safe and sustainable alternative to PVC,” said Jose Reyes, Global Strategic Market Manager, Celanese. “EVA has been safely used in medical devices for more than 35 years and has been applied to a variety of applications, including parenteral nutrition bags, cryogenic stem cell bags, infusion tubing, and cell culture bags, to name a few.”

Ateva® G Medical grade EVA copolymers provide up to 40 percent vinyl acetate content that deliver flexibility and weldability without the need for additional additives. Ateva® G Medical copolymers may also be available in custom medical development grades. Celanese provides complete regulatory, processing and technical service and support throughout the medical device development process.

Celanese experts will present the latest developments in the use of EVA in medical applications at a complimentary technical seminar during the event.

Speakers: Richard Li and Jose Reyes
Title: EVA Copolymers – Sustainable Solutions for Regulated Medical Devices and Packaging Applications
Date: Friday, May 15, 2015 – 13:30 p.m. to 16:30 p.m.
Location: Pacifico Convention Plaza, Meeting Room C0-08, Building C

For more information about EVA copolymers from Celanese, please see the following resources:

• Ateva® G Medical brochure (Chinese and English):
  http://celanese.com/Tradeshows/2015/ICMD-2015.aspx
• White Paper: “Innovative Uses of Ethylene Vinyl Acetate Polymers for Advancing Healthcare”
  http://info.celanese.com/download-ateva-medical-whitepaper
• Ateva® G Medical grades:
  http://celanese.com/eva-polymers/products/Ateva-G-Medical-Grade.aspx

About Celanese

Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. With sales almost equally divided between North America, Europe and Asia, the company uses the full breadth of its global chemistry, technology and business expertise to create value for customers and the corporation. Celanese partners with customers to solve their most critical needs while making a positive impact on its communities and the world. Based in Dallas, Texas, Celanese employs approximately 7,500 employees worldwide and had 2014 net sales of $6.8 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.

All registered trademarks are owned by Celanese International Corporation or its affiliates.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company or customers will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.